Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

16 Apr 2019

Abstract excerpt

Antiphospholipid Syndrome (APS) is an autoimmune disorder, characterized by pregnancy morbidity and/or a hypercoagulable state involving the venous or the arterial vasculature and associated with antiphospholipid antibodies (aPL), including anti-cardiolipin antibodies (aCL), anti-beta2-glycoprotein I (anti-ß2GPI) and Lupus anticoagulant (LA). In recent years there have been many advances in the understanding of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Systemic Lupus Erythematosus Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31040845
DOI: 10.3389/fimmu.2019.00764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics ApproachesPMID 31040845Read ↗

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndromeSemantic proximity Read ↗

Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping reviewSemantic proximity Read ↗

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic AnalysesSemantic proximity Read ↗

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)Semantic proximity Read ↗

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune DisordersSemantic proximity Read ↗

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic MechanismsSemantic proximity Read ↗

ANTIPHOSPHOLIPID SYNDROME AS A MODIFIER OF CLINICAL PHENOTYPES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CASE-CONTROL STUDY.Semantic proximity Read ↗

Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.Semantic proximity Read ↗

Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupusSemantic proximity Read ↗

Extracellular Vesicles in the Antiphospholipid SyndromeSemantic proximity Read ↗

Pathogenesis of the Antiphospholipid SyndromeSemantic proximity Read ↗

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.